Mina Sooch - 10 Jan 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role: President and CEO, Director
Signature: /s/ Emily J. Johns, by Power of Attorney
Issuer symbol: IRD
Transactions as of: 10 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 12 Jan 2023, 17:08:04 UTC
Previous filing: 14 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+134,456	+45%	$0.000000	430,501	10 Jan 2023	Direct	F1
holding	OCUP	Common Stock						50,000	10 Jan 2023	By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+201,683		$0.000000	201,683	10 Jan 2023	Common Stock	201,683	$3.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 10, 2023.
F2	The option will vest with respect to 50,420 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter.